Skip to content

NDL IBD

Active Private limited companyfounded 2024active for 2 yearsRue Entre Deux Tiges 10, 4140 SprimontKBO/BCE: BE 1015.220.311

Lifetime

2 annual accounts with figures on one time axis
peak of €14,728 in 2025
€14,728▲ 23×
peak of €11,017 in 2025
€11,017▲ 31×
peak of €13,872 in 2025
€13,872▲ 386%
€4,395▲ 153%
Board1 name since 2024
1 director
Documentsfilings and deeds
09-07-202622 days before the deadline
2025micro format
Gross margin from €642 to €14,728Result from €355 to €11,017Equity from €2,855 to €13,872Debts from €1,737 to €4,395Cash from €498 to €8,091

Key points

from the 2025 annual accounts

Turnover

≈ €91,000 estimated

The micro format states no turnover.

Position in the sector

€13,872

Less equity than 86% of companies in human health. The sector median is €125,188, over 21,387 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as NDL IBD has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for NDL IBD. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 21-10-2024
Board & ownership

Recent changes

Registered office moved from Chaudfontaine to Sprimont The registered office moved from Rue Joseph Deflandre 60/A12, 4053 Chaudfontaine to Rue Entre Deux Tiges 10, 4140 Sprimont · General meeting of 24-01-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:1015220311
Incorporation Founding capital of €2,500, 100 shares · Founded by (comparant fondateur) · appointed as director · published on 21-10-2024 · Gazette deed
First establishment At the time the registered office was still in Chaudfontaine, Rue Joseph Deflandre 60/A12.
All 7 events

Comparable companies

same main activity, similar in size and age
Company
NDL IBD Sprimont €18,267 €14,728 75.9% -
JDEL AIR Arlon €18,732 €13,698 68.0% -
DOCTEUR FREDERIQUE DEPIERREUX Oreye €20,216 €17,087 77.4% -
DOCTEUR GERALDINE BRICHANT Liège €16,740 €12,626 77.4% -
C. Deltour Ghent €20,418 €18,302 77.9% -
Dr. Simon Van Roy Aartselaar €23,421 €16,840 49.4% -
SHP Medische Praktijk Berchem-Sainte-Agathe €19,887 €19,132 85.0% -

These companies have the same main activity as NDL IBD: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €16,700 and €23,400, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 17-10-2024Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.366.252.6424140 Sprimont, registered on 17-10-2024
Financial year end
31 December
Peppol
Reachable since 13-11-2025
Company details

Annual accounts 2025

€18,267▲ 298%
Filing
Filed on 09-07-2026, 22 days before the end of the filing period
Financials

Insights on NDL IBD

NDL IBD has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €13,872 and a net result of €11,017.

Its solvency ranks better than 65% of 21,385 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NDL IBD

What is the company number of NDL IBD?
The company number of NDL IBD is 1015.220.311. The VAT number is the same number with BE in front: BE 1015.220.311.
Where is NDL IBD based?
The registered office is at Rue Entre Deux Tiges 10, 4140 Sprimont.Company details
What does NDL IBD do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of NDL IBD?
NDL IBD is a private limited company (BV).
When was NDL IBD founded?
NDL IBD was founded on 17-10-2024.
Is NDL IBD still active?
Yes, NDL IBD is an active enterprise in the KBO register.
What is the turnover of NDL IBD?
The turnover in financial year 2025 is about €91,000. This figure is estimated from the gross margin of €14,728 and 52 comparable companies (NACE 86). It probably lies between €63,000 and €160,000. It is a rough estimate.Financials
Is NDL IBD profitable?
In financial year 2025, NDL IBD made a profit of €11,017.
Where can I find the annual accounts of NDL IBD?
NDL IBD filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NDL IBD due?
NDL IBD must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.